In an industrial corner of Singapore, multiplying steadily in bioreactors heated precisely to 82 degrees, real shrimp meat is being grown from samples of the crustaceans microscopic cells.
Fed a nutrient-rich soup meant to mimic its diet in the wild, a single cell can reproduce over a trillion times into a mound of gray translucent flesh. Think of it as meat growing without all the other parts of the animal, including that chalky black vein.
The venture is being led by Sandhya Sriram and a team of scientists, who are attempting to upend one of the cornerstones of dim sum. Srirams company, Shiok Meats, is named after Singaporean slang used to declare something delicious.
Similar work is being done across the world at other startups and research labs to grow beef, pork, chicken and high-end specialty products such as bluefin tuna and foie gras, but Srirams company is the only one known to be focused on re-creating shrimp, a staple in many Asian dishes.
Shioks finished product this reporter was unable to try it because no outsiders are allowed to visit its headquarters during the pandemic possesses the texture of ground shrimp and has already been tested to make shumai, the Cantonese dim sum mainstay with the yellow dumpling wrapper. But its applications are potentially manifold in Chinese-centric cuisine.
Shrimp shumai made with lab-grown shrimp from Shiok Meats.
(Shiok Meats)
You could layer a dollop of it over a raft of tofu, steam it and douse it with a slightly sweeter soy sauce. It could be squeezed out of a piping bag into a simmering hot pot broth. And it might be the kind of thing youd want to roll into balls, bread and deep-fry.
Eventually Sriram, who cofounded the company two years ago, would like to move beyond ground shrimp meat to produce crab, lobster and a structured deshelled shrimp, one convincing enough to hang off the edge of a glass filled with cocktail sauce.
We can 3-D print the tail if you want, she said.
Singapore has emerged as a leading player in the budding technology once derided as Frankenmeat after Dutch researcher Mark Post unveiled the first test-tube burger to a panel of food critics at a news conference in London seven years ago.
Researchers have been able to drive down the price of the meat, which is called cell cultured meat or clean meat, from the nearly $300,000 it cost to produce Posts debut patty though not enough to actually sell it to the public yet. Shioks shumai, for example, cost $300 apiece.
In whats been described as an edible space race, at least 55 companies worldwide are now involved in developing some variety of cell cultured meat, according to the Good Food Institute, a Washington-based nonprofit advocating alternatives to animal agriculture.
That includes one in Hong Kong that re-creates fish maw or bladder, a delicacy often used in soups; an Australian startup thats growing kangaroo meat; and a company in China thats looking to re-create pork in a country where rising demand for meat will test the limits of the worlds supply. Last year, an Israeli startup successfully grew cow muscle tissue on the International Space Station.
The sciences emergence has provoked existential questions about the provenance of meat, prompting vegans to contemplate whether the technology represents a sort of loophole if it doesnt harm animals, and Jewish and Muslim religious leaders to ponder if the lab-grown pork could be deemed kosher or halal.
Eventually, the technology could allow for novel kinds of meat to be made, presenting chefs with unusual possibilities.
Imagine when you can tailor the taste of any piece of meat, said Ryan Bethencourt, the San Francisco-based cofounder of biotech accelerator IndieBio, who provided Shiok with its initial seed funding. What does pork with salmon fat taste like? What does a mix between Wagyu beef and other heritage beef steak lines taste like? What about meat that tastes both sweet and sour?
Inside the lab at Singapore-based Shiok Meats, where theyre growing shrimp.
(Shiok Meats)
Investors are pouring hundreds of millions into the industry, inspired by the success of plant-based meat companies Beyond Meat and Impossible, which helped demystify alternatives to eating farm animals for a far wider audience than previously thought possible.
Financial backers in the burgeoning field also include giants in the conventional meat industry such as Tyson, Cargill and Bell Food Group. Bill Gates, Richard Branson and Li Ka-shing, one of Hong Kongs richest tycoons, are betting on the meats success as are massive investment funds such as SoftBank and the Singapore governments Temasak.
Cell cultured burgers, chicken tenders and other breakthroughs are still a year or more away from landing in restaurants and grocery stores, experts say, but current events have heightened the urgency to develop more choices for meat.
The COVID-19 pandemic exposed flaws in the conventional meat industry after workers at processing plants in the U.S. and Europe suffered massive outbreaks of the disease and the industrys supply chain buckled under the crisis, leading to shortages, price hikes and purchasing limits.
Critics of conventional meat say the virus provides one more reason to turn away from an industry that has wreaked havoc on the natural environment, served as a vector for infectious diseases like salmonella and E. coli and, through its rampant use of antibiotics on crowded and inhumane factory farms, undermined human health.
But its not entirely clear whether cell cultured meat is safer and healthier. Companies are loathe to share data, choosing instead to operate in secretive silos to protect their intellectual property. Shiok denied a request to view or taste-test its raw product for this story, citing a pending patent. Bethencourt later provided The Times with video of the companys lab-grown shrimp cells under a microscope.
Theyve achieved their objective of making scalable cell-based shrimp, he said.
The environmental benefits of clean meat could be significant. The Good Food Institute estimates cell cultured beef will cut the amount of land used by cattle to produce regular beef by 95% and the amount of emissions by at least 74%.
That could certainly win converts, but its how the meat tastes and feels that will ultimately determine the industrys success.
Not all companies who make this are created equal, said Chase Purdy, an expert on cultured meat and author of Billion Dollar Burger: Inside Big Techs Race for the Future of Food.
Purdy tasted lab-grown foie gras, duck chorizo and ground beef but nothing impressed him more than a chicken tender made by Berkeleys Memphis Meats, with strands of muscle that peeled apart with startling authenticity.
Its really hard to get cells to grow in that linear, structured way, Purdy said.
That might be the exception. Anyone hoping for a facsimile of a dry-aged Porterhouse steak or a loin of Berkshire pork crowned with a sheet of crackling might have to make do with ground meat much easier to replicate for tacos, pasta sauces and burgers for some time.
Re-creating recognizable butcher cuts with complex layers of muscles and fat (think of the patchwork of beef chuck or the mosaic of fat and muscle on the rim of a rib-eye) remains the elusive grail for the industry one thats being tackled by several companies.
Were still at the prototype stage, showing proof of concept and proof of value, said William Chen, the Michael Fam Chair professor and director of food science and technology at Nanyang Technological University Singapore, which is working on growing steak. Think of it as a car. Were able to make a basic sedan. But to make beef steak, we need to build a racing car.
The simplicity of shrimp is what drew Sriram, 35, to the crustacean, which unlike beef, pork or chicken comprises one uniform muscle.
From left, Shiok Meats CTO Ka Yi Ling and CEO Sandhya Sriram.
(Shiok Meats)
Being in Asia was also a plus. Shioks own surveys, and at least one study, suggest Asians are more willing to try novel foods like clean meat than people in the West.
A stem-cell biologist born in India and raised in the Middle East before moving to Singapore, Sriram was thrilled when she realized cell cultured shellfish was an open field.
Asia consumes three-quarters of the worlds supply of shrimp. And the industrys notorious practices, which include slave labor, pollution and the overuse of antibiotics, convinced Sriram there would be a market for an alternative.
Shiok was founded by Sriram and fellow scientist Ka Yi Ling, 32. The pair initially struggled to find private lab space to rent, settling briefly at a marine institute on a mostly secluded island that required careful adherence to a ferry schedule, lest they wanted to stay a night alone on the eerie redoubt.
By 2019, the pair had moved out and developed a prototype that required Sriram, a vegetarian, to eat shrimp for the first time so that she could compare the two.
I could definitely smell and taste the ocean, she said of the creation.
Driving down costs remains the biggest hurdle. Shioks proto-shrimp costs $5,000 a kilogram, which is about $2,268 a pound, mostly due to the price of the nutrient fluids needed to feed the cells. Access to more affordable nutrients has reduced the cost of Shioks meat to $3,500 a kilogram, or about $1,588 a pound. The goal is to make Shioks shrimp 100 times cheaper by the first half of next year.
Unlike the U.S., Singapore has developed regulations for the sale of cultured meat.
The tiny Southeast Asian country, whose entire width is the distance between Burbank and El Segundo, has supported the technology with tax breaks and grants to bolster a government campaign to break the countrys near-total reliance on imported food by 2030.
Singapore is doing more of its own investing and is the most receptive from a regulatory angle to greenlighting this to go to market first, Purdy said. It will likely be a restaurant in Singapore that serves this up to consumers for the first time in history.
Read more:
Singapore startup Shiok Meats re-creates shrimp in the lab - Los Angeles Times
- The therapeutic potential of stem cells - PubMed Central (PMC) - November 12th, 2024
- Stem Cell Therapy Market Is Projected To Achieve A Market Value Of USD 3.40 Bn. By 2030, Reflecting A Robus... - WhaTech - October 18th, 2024
- Doctor who provided ineffective stem cell therapies disciplined 6 years after investigation began - CBS Chicago - October 15th, 2024
- Study reveals the benefits and downside of fasting - Big Think - September 28th, 2024
- Tiny vesicles from umbilical cord blood may have therapeutic benefit - Parkinson's News Today - September 28th, 2024
- The Stem Cell Solution Review: Is This Program the Future of Anti-Aging and Recovery? - Enumclaw Courier-Herald - September 28th, 2024
- Cell and Gene Therapy Research To Benefit From New Stem Cell Collection Center - Technology Networks - September 25th, 2024
- Stem Cell Restore: A Full Review of Its Role in Promoting Regeneration and Vitality - Islands' Sounder - September 18th, 2024
- Is fasting good for you? A new study reveals some hidden risks and benefits of the practice - Business Insider India - August 31st, 2024
- Study reveals the benefits and downside of fasting - MIT News - August 27th, 2024
- Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain - August 22nd, 2024
- Oragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed Patients - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Niclas Lindstedt - August 22nd, 2024
- PharmaTher’s Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine’s Potential to Bind to Monkeypox (Mpox) Proteins - August 22nd, 2024
- BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA PHARMACEUTICALS. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY... - August 22nd, 2024
- Eyenovia Announces Pricing of $5.14 Million Public Offering - August 22nd, 2024
- Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management... - August 22nd, 2024
- Clearmind Medicine Granted U.S. Patent Approval for Binge Behavior Treatment - August 22nd, 2024
- SIGA Announces New Contract Awarded by U.S. Department of Defense for the Procurement of $9 Million of TPOXX® - August 22nd, 2024
- MDxHealth Reports Q2 and Half Year 2024 Results - August 22nd, 2024
- Bavarian Nordic Receives 440,000 Dose Contract to Supply Smallpox and Mpox Vaccines for Undisclosed European Country - August 22nd, 2024
- Brains Bioceutical Set to Achieve One of the World’s First CEP for Cannabidiol Certification with the European Directorate for the Quality of... - August 22nd, 2024
- Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility - August 22nd, 2024
- Certara to Participate in Upcoming Investor Conferences - August 22nd, 2024
- Orion Corporation: Managers’ transactions – Satu Ahomäki - August 22nd, 2024
- Bavarian Nordic Announces First Half 2024 Results - August 22nd, 2024
- BioCryst to Present at Upcoming Investor Conferences - August 22nd, 2024
- Zymeworks Announces Participation in Upcoming Investor Conferences - August 22nd, 2024
- MediWound Reports Second Quarter 2024 Financial Results and Provides Company Update - August 14th, 2024
- Viracta Therapeutics Announces Positive Data from the Phase 2 NAVAL-1 Trial, Regulatory Progress, and Updated Nana-val Clinical Development Plan - August 14th, 2024
- Shock Top and Gator Athletics Partner to Introduce First-Ever Craft Beer Sponsorship of the Florida Athletic Department - August 14th, 2024
- IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update - August 14th, 2024
- Achilles Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Updates - August 14th, 2024
- Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - August 14th, 2024
- Evaxion Announces Business Update and Second Quarter 2024 Financial Results - August 14th, 2024
- Galera Announces Board Approval of Complete Liquidation and Dissolution - August 14th, 2024
- Outlook Therapeutics® Reports Financial Results for Third Quarter Fiscal Year 2024 and Provides Corporate Update - August 14th, 2024
- Viracta Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update - August 14th, 2024
- Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research - August 14th, 2024
- CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update - August 14th, 2024
- Panavance Therapeutics Announces Foundational Publication of Misetionamide (GP-2250) in Ovarian Cancer in the Journal, Cancer Medicine - August 14th, 2024
- Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - August 14th, 2024
- Veralox Therapeutics Announces EMA Orphan Drug Designation for VLX-1005 - August 14th, 2024
- Verrica Pharmaceuticals Announces Positive Preliminary Topline Results from Part 2 of Phase 2 Clinical Study of VP-315, an Investigational Oncolytic... - August 14th, 2024
- Verrica Pharmaceuticals Reports Second Quarter 2024 Financial Results - August 14th, 2024
- Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons - August 14th, 2024
- Atsena Therapeutics Receives Rare Pediatric Disease Designation from the U.S. FDA for ATSN-201 Gene Therapy to Treat X-linked Retinoschisis - August 14th, 2024
- Aquestive Therapeutics Comments on Recent FDA Approval of Non-Injection-Based Epinephrine Product for the Treatment of Anaphylaxis and Reiterates... - August 14th, 2024
- What Is Stem Cell Therapy? How Does It Work? - ThePrint - August 6th, 2024
- New Study Shows Short-Term Benefits of Stem Cell Therapy for MS Patients, But Long-Term Efficacy Remains Unclear - Managed Healthcare Executive - July 26th, 2024
- Cord Blood Awareness Month: Advantages of cord blood banking, things to keep in mind - Moneycontrol - July 10th, 2024
- Neural Stem Cell Plasticity: Advantages in Therapy for the Injured Central Nervous System - Frontiers - June 28th, 2024
- Harnessing benefits of stem cells for heart regeneration | ASU News - ASU News Now - June 21st, 2024
- 'Didn't know this would be possible': Autistic teen's mom on stem cell therapy benefits - WZTV - May 6th, 2024
- John Cleese says he's been spending 17,000 annually on stem cell therapy to 'buy a few extra years' - Yahoo News UK - April 24th, 2024
- Promethera Bets Liver-Derived Stem Cells Will Offer Benefits In NASH - Scrip - April 24th, 2024
- Stem Cell Therapies: Is This The Future Of Wellness? - Grazia USA - April 20th, 2024
- Signal of Benefit for Stem Cell Therapy in Progressive MS - Medscape - March 7th, 2024
- The Controversies Surrounding Stem Cell Therapy for Autism - The Portugal News - February 24th, 2024
- Benefits of Stem Cell Therapy - News Channel 5 Nashville - February 7th, 2024
- What is Stem Cell Therapy & How It Helps Others - Publicist Paper - January 31st, 2024
- A guide to stem cell therapy in Thailand - Thaiger - January 4th, 2024
- Half of pediatric patients with aHUS benefit from Soliris after... - AHUS News - December 21st, 2023
- Real world analysis on the determinants of survival in primary ... - Nature.com - December 5th, 2023
- The Best Beauty Gifts According To People Who Really Know Skin Care - HuffPost - December 5th, 2023
- The Eyepopping Factory Construction Boom in the US - WOLF STREET - December 3rd, 2023
- Benefit of Neoadjuvant Therapy Illustrated During ESMO Congress ... - Targeted Oncology - December 1st, 2023
- Benefits Outweigh Risks as FDA Inspects CAR-T Cell Therapy ... - Curetoday.com - December 1st, 2023
- Review What Real Cavityn Customers Say About Benefits and Side ... - Seattle Weekly - December 1st, 2023
- 'There is a Scientific Fraud Epidemic' - Slashdot - Slashdot - December 1st, 2023
- 15 Best Hydrating Serums to Soothe Any Skin Type 2023 - Town & Country - December 1st, 2023
- Innovations in Cosmetic Dermatology: A Glimpse into the Future - APN News - December 1st, 2023
- FDA Probes New Cases of Cancer That May Stem From Cancer Cell ... - MedCity News - November 29th, 2023
- Use of plant stem cells in topical formulations on the rise - CosmeticsDesign.com USA - November 29th, 2023
- Stem cell-based treatment controls blood sugar in people with Type ... - EurekAlert - November 29th, 2023
- Biologics Market is projected to grow at a CAGR of 8.5% by 2034: Visiongain - Yahoo Finance - November 29th, 2023
- Scientists devise new technique that can pinpoint the causes and ... - EurekAlert - November 29th, 2023
- Global Advanced Therapy Medicinal Products Market is on the brink ... - PharmiWeb.com - November 29th, 2023
- Introducing Orgavalue - The 2023 EIT InnoStars Awards winner - EU-Startups - November 29th, 2023
- Episode 160: Euan Ashley discusses precision medicine and the ... - IHMC - November 29th, 2023
Recent Comments